Brief: Emergent Biosolutions Receives U.S. FDA Approval On Supplemental New Drug Application For Narcan® Nasal Spray To Be Packaged In A New Carrying Case, Making Life-Saving Naloxone More Accessible For Everyday Preparedness
14/01/2026 13:01
Jan 14 (Reuters) - Emergent BioSolutions Inc EBS.N: EMERGENT BIOSOLUTIONS RECEIVES U.S. FDA APPROVAL ON SUPPLEMENTAL NEW DRUG APPLICATION FOR NARCAN® NASAL SPRAY TO BE PACKAGED IN A NEW CARRYING CASE, MAKING LIFE-SAVING NALOXONE MORE ACCESSIBLE FOR EVERYDAY PREPAREDNESS Source text: ID:nGNX53g4yh Further company coverage: EBS.N ((Reuters.Briefs@thomsonreuters.com;))